The Shotlee Journal
Browse Shotlee articles about Weight Management.
Showing 9 / 869 Weight Management articles
The growing popularity of GLP-1 medications, including Wegovy, is having a notable impact on retail spending, particularly in the pharmaceutical sector. This article delves into the economic implications and what it means for consumers and businesses.
Popular GLP-1 medications, known for their weight loss efficacy, are now showing potential to combat arthritis inflammation. Discover what this groundbreaking research means for joint health.
Concerns are mounting over the integrity of the pharmaceutical supply chain as the FDA takes action against a Chinese supplier for questionable practices involving critical GLP-1 drug ingredients. This development raises questions about the safety and reliability of active pharmaceutical ingredients used in popular weight loss and diabetes medications.
The launch of GLP-1 agonists like Ozempic and Wegovy has not only transformed weight management but also sparked an unexpected trend: a significant increase in vitamin supplement sales. This article delves into the potential reasons behind this phenomenon and what it signifies for individuals managing their health with these powerful medications.
Two generic versions of Ozempic have arrived in Canadian pharmacies, offering diabetes and weight loss patients significant cost savings compared to the brand-name medication.
Eli Lilly's Retatrutide has shown remarkable weight loss potential in Phase 3 trials. We break down the TRIUMPH-1 results, safety data, and what patients can expect.
Many women starting GLP-1 therapies experience significant weight loss, only to find their menopausal symptoms—like hot flashes and sleep issues—intensify. This phenomenon is often overlooked because rapid fat loss directly interacts with the body's declining estrogen production, creating a complex hormonal shift that many prescribers are not trained to address.
As GLP-1 medications gain popularity for weight loss and diabetes management, understanding their impact on nutrient absorption is crucial. This article explores the link between these powerful drugs and the rising demand for supplements, offering insights from medical professionals and research.
Eli Lilly's experimental drug retatrutide has demonstrated unprecedented weight loss results in a pivotal trial. This article delves into its mechanisms, efficacy, safety, and how it stacks up against current leading weight loss medications like Ozempic and Wegovy.
